skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Show only
Refined by: Database: Freely Accessible Journals remove top level: Digital Resources/Online E-Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
10 LESSONS FOR MANAGING CIVIL UNREST
10 LESSONS FOR MANAGING CIVIL UNREST
Material Type:
Article 		Add to My Research

10 LESSONS FOR MANAGING CIVIL UNREST

EMS World, 2020-06, Vol.49 (6), p.22-25

Copyright HMP Communications Jun 2020 ;ISSN: 2158-7833 ;EISSN: 2159-3078

Full text available

Citations Cited by
2
10 LESSONS FOR MANAGING CIVIL UNREST: Three EMS leaders who have been through it share their key wisdom
10 LESSONS FOR MANAGING CIVIL UNREST: Three EMS leaders who have been through it share their key wisdom
Material Type:
magazinearticle 		Add to My Research

10 LESSONS FOR MANAGING CIVIL UNREST: Three EMS leaders who have been through it share their key wisdom

EMS world, 2020-06, Vol.49 (6), p.22

COPYRIGHT 2020 HMP Communications, LLC ;ISSN: 2158-7833 ;EISSN: 2159-3078

Full text available

Citations Cited by
3
1111 Increasing access and quality of care for individuals from underrepresented communities living with lupus: insights from qualitative interviews with patients and physicians
1111 Increasing access and quality of care for individuals from underrepresented communities living with lupus: insights from qualitative interviews with patients and physicians
Material Type:
Article 		Add to My Research

1111 Increasing access and quality of care for individuals from underrepresented communities living with lupus: insights from qualitative interviews with patients and physicians

Lupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A38-A39 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-lupus21century.54

Full text available

Citations Cited by
4
1112 IMPACT study: can we conduct a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome?
1112 IMPACT study: can we conduct a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome?
Material Type:
Article 		Add to My Research

1112 IMPACT study: can we conduct a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome?

Lupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A39-A39 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-lupus21century.55

Full text available

Citations Cited by
5
1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis
1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis
Material Type:
Article 		Add to My Research

1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A82-A84 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.82

Full text available

Citations Cited by
6
117 Ending the HIV/AIDS Pandemic: A Realistic Goal
117 Ending the HIV/AIDS Pandemic: A Realistic Goal
Material Type:
Article 		Add to My Research

117 Ending the HIV/AIDS Pandemic: A Realistic Goal

Journal of acquired immune deficiency syndromes (1999), 2012-04, Vol.59, p.1 [Peer Reviewed Journal]

Copyright Lippincott Williams & Wilkins Apr 2012 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;CODEN: JDSRET

Full text available

Citations Cited by
7
1201 IMPACT Study: Preliminary results of a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome
1201 IMPACT Study: Preliminary results of a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome
Material Type:
Article 		Add to My Research

1201 IMPACT Study: Preliminary results of a trial with a biologic to prevent preeclampsia in women with antiphospholipid syndrome

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A84-A85 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.83

Full text available

Citations Cited by
8
13 Ways of Looking at Boy/Girl Twins
13 Ways of Looking at Boy/Girl Twins
Material Type:
magazinearticle 		Add to My Research

13 Ways of Looking at Boy/Girl Twins

TriQuarterly, 2017-07 (152)

Copyright TriQuarterly Summer/Fall 2017 ;EISSN: 2330-6858

Full text available

Citations Cited by
9
13 Management of paediatric lupus
13 Management of paediatric lupus
Material Type:
Article 		Add to My Research

13 Management of paediatric lupus

Lupus science & medicine, 2023-09, Vol.10 (Suppl 2), p.A7-A8 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-la.13

Full text available

Citations Cited by
10
15 Strategies for minimizing corticosteroid exposure in SLE
15 Strategies for minimizing corticosteroid exposure in SLE
Material Type:
Article 		Add to My Research

15 Strategies for minimizing corticosteroid exposure in SLE

Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A8-A8 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.15

Full text available

Citations Cited by
11
16 Targeting remission and low disease activity in SLE
16 Targeting remission and low disease activity in SLE
Material Type:
Article 		Add to My Research

16 Targeting remission and low disease activity in SLE

Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A8-A9 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.16

Full text available

Citations Cited by
12
17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days
17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days
Material Type:
magazinearticle 		Add to My Research

17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days

Managed care, 2005-10, Vol.14 (10), p.58-63

ISSN: 1062-3388 ;PMID: 16277194

Full text available

Citations Cited by
13
17 Management of neuropsychiatric SLE
17 Management of neuropsychiatric SLE
Material Type:
Article 		Add to My Research

17 Management of neuropsychiatric SLE

Lupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A9-A9 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.17

Full text available

Citations Cited by
14
18 Management of pregnancy in SLE and APS
18 Management of pregnancy in SLE and APS
Material Type:
Article 		Add to My Research

18 Management of pregnancy in SLE and APS

Lupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A9-A10 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.18

Full text available

Citations Cited by
15
2003-2004 annual report of the College of Human Ecology
2003-2004 annual report of the College of Human Ecology
Material Type:
magazinearticle 		Add to My Research

2003-2004 annual report of the College of Human Ecology

Human ecology (Ithaca, N.Y.), 2005-04, Vol.33 (1), p.14

COPYRIGHT 2005 Cornell University, Human Ecology ;ISSN: 1530-7069 ;EISSN: 2163-520X

Full text available

Citations Cited by
16
2008 Election
2008 Election
Material Type:
magazinearticle 		Add to My Research

2008 Election

The women's health activist, 2008-03, Vol.33 (2), p.6A

Copyright National Women's Health Network Mar/Apr 2008 ;ISSN: 1547-8823

Full text available

Citations Cited by
17
2009 ANZCA ANNUAL SCIENTIFIC MEETING ABSTRACTS
2009 ANZCA ANNUAL SCIENTIFIC MEETING ABSTRACTS
Material Type:
Article 		Add to My Research

2009 ANZCA ANNUAL SCIENTIFIC MEETING ABSTRACTS

Pain medicine (Malden, Mass.), 2009-09, Vol.10 (6), p.1151-1158 [Peer Reviewed Journal]

American Academy of Pain Medicine ;ISSN: 1526-2375 ;EISSN: 1526-4637 ;DOI: 10.1111/j.1526-4637.2009.00693.x

Full text available

Citations Cited by
18
2011-2012: the medical year in review: our roundup of study findings that could transform disease and condition management
2011-2012: the medical year in review: our roundup of study findings that could transform disease and condition management
Material Type:
Article 		Add to My Research

2011-2012: the medical year in review: our roundup of study findings that could transform disease and condition management

Pharmacy times, 2012-06, Vol.78 (6), p.S40

COPYRIGHT 2012 Intellisphere, LLC ;ISSN: 0003-0627 ;EISSN: 2168-7234

Full text available

Citations Cited by
19
2022 SCHOLARSHIP RECIPIENTS
2022 SCHOLARSHIP RECIPIENTS
Material Type:
Article 		Add to My Research

2022 SCHOLARSHIP RECIPIENTS

International social science review, 2022-12, Vol.98 (4), p.25-31 [Peer Reviewed Journal]

COPYRIGHT 2022 Pi Gamma Mu ;Copyright Pi Gamma Mu 2022 ;ISSN: 0278-2308 ;EISSN: 2332-0419

Full text available

Citations Cited by
20
2022 SCHOLARSHIP RECIPIENTS
2022 SCHOLARSHIP RECIPIENTS
Material Type:
Article 		Add to My Research

2022 SCHOLARSHIP RECIPIENTS

International social science review, 2023-12, Vol.99 (44) [Peer Reviewed Journal]

COPYRIGHT 2023 Pi Gamma Mu ;ISSN: 0278-2308 ;EISSN: 2332-0419

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,501)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1974  (19)
  2. 1974 To 1985  (57)
  3. 1986 To 1997  (399)
  4. 1998 To 2010  (1,924)
  5. After 2010  (3,075)
  6. More options open sub menu

Language 

  1. English  (5,374)
  2. Japanese  (106)
  3. Chinese  (21)
  4. Spanish  (16)
  5. Arabic  (9)
  6. Korean  (8)
  7. Portuguese  (8)
  8. French  (7)
  9. Swedish  (1)
  10. Norwegian  (1)
  11. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait